Education
About Us
Working with TipRanks
Follow Us
ImmunityBio (IBRX)
NASDAQ:IBRX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 14.74M | $ 622.00K | $ 240.00K | $ 934.00K | $ 605.00K |
| Gross Profit | $ 14.74M | $ 622.00K | $ -23.95M | $ 934.00K | $ -8.54M |
| Operating Income | $ -344.18M | $ -362.25M | $ -351.30M | $ -330.28M | $ -220.88M |
| EBITDA | $ -264.43M | $ -436.18M | $ -335.51M | $ -315.38M | $ -187.93M |
| Net Income | $ -413.56M | $ -583.20M | $ -417.32M | $ -349.85M | $ -224.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 149.81M | $ 266.46M | $ 107.18M | $ 317.12M | $ 96.06M |
| Total Assets | $ 382.93M | $ 504.45M | $ 362.36M | $ 468.91M | $ 221.38M |
| Total Debt | $ 42.29M | $ 726.72M | $ 723.77M | $ 645.66M | $ 275.55M |
| Net Debt | $ -101.14M | $ 461.27M | $ 619.13M | $ 464.56M | $ 240.63M |
| Total Liabilities | $ 871.06M | $ 1.09B | $ 812.18M | $ 712.82M | $ 339.87M |
| Stockholders' Equity | $ -488.13M | $ -586.99M | $ -447.33M | $ -242.17M | $ -119.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -398.12M | $ -397.34M | $ -436.90M | $ -307.98M | $ -173.39M |
| Operating Cash Flow | $ -391.24M | $ -366.76M | $ -337.51M | $ -274.42M | $ -171.72M |
| Investing Cash Flow | $ -12.25M | $ -30.47M | $ 27.30M | $ -84.89M | $ -19.81M |
| Financing Cash Flow | $ 281.63M | $ 558.34M | $ 233.61M | $ 505.44M | $ 150.68M |